Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

[The B cell in the pathogenesis of rheumatoid arthritis].

Díaz-González JF, Ferraz Amaro I.

Reumatol Clin. 2007 Jul;3(4):176-82. doi: 10.1016/S1699-258X(07)73617-3. Epub 2008 Nov 13. Spanish.

2.
3.

B-cell-targeted therapy for systemic lupus erythematosus.

Sabahi R, Anolik JH.

Drugs. 2006;66(15):1933-48.

PMID:
17100405
4.

Beneficial autoimmunity participates in the regulation of rheumatoid arthritis.

Zohar Y, Wildbaum G, Karin N.

Front Biosci. 2006 Jan 1;11:368-79. Review.

PMID:
16146738
5.

Roles of B cells in rheumatoid arthritis.

Silverman GJ, Carson DA.

Arthritis Res Ther. 2003;5 Suppl 4:S1-6. Epub 2003 Dec 2. Review.

6.

Immunopathologic role of B lymphocytes in rheumatoid arthritis: rationale of B cell-directed therapy.

Martinez-Gamboa L, Brezinschek HP, Burmester GR, Dörner T.

Autoimmun Rev. 2006 Aug;5(7):437-42. Epub 2006 Mar 9. Review.

PMID:
16920569
7.

[Pathology and progression of intra-articular inflammation in rheumatoid arthritis].

Geiler G.

Verh Dtsch Ges Pathol. 1996;80:46-57. Review. German.

PMID:
9065054
8.

Pathogenesis of rheumatoid arthritis.

Weyand CM, Goronzy JJ.

Med Clin North Am. 1997 Jan;81(1):29-55.

PMID:
9012754
9.

B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives.

Nakken B, Munthe LA, Konttinen YT, Sandberg AK, Szekanecz Z, Alex P, Szodoray P.

Autoimmun Rev. 2011 Nov;11(1):28-34. doi: 10.1016/j.autrev.2011.06.010. Epub 2011 Jul 14. Review.

PMID:
21777703
10.

Biological therapies directed against cells in autoimmune disease.

Hasler P.

Springer Semin Immunopathol. 2006 Jun;27(4):443-56. Epub 2006 Apr 28. Review.

PMID:
16738955
11.

[The humoral response in rheumatoid arthritis and the effect of B-cell depleting therapy].

Thurlings RM, Vos K, Gerlag DM, Tak PP.

Ned Tijdschr Geneeskd. 2006 Jul 29;150(30):1657-61. Review. Dutch.

PMID:
16922350
12.

[Pathogenesis and immunopathology of rheumatoid polyarthritis].

Cantagrel A.

Rev Prat. 1997 Nov 15;47(18):1992-7. French.

PMID:
9501615
13.

[B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].

Kondo S, Akashi T, Katsuta H, Iwakiri R, Anzai K, Nagafuchi S, Niho Y, Harada M.

Fukuoka Igaku Zasshi. 2005 Apr;96(4):86-92. Review. Japanese.

PMID:
15991605
14.

[B lymphocyte].

Hasegawa M.

Nihon Rinsho Meneki Gakkai Kaishi. 2005 Oct;28(5):300-8. Review. Japanese.

15.

B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity.

Yanaba K, Hamaguchi Y, Venturi GM, Steeber DA, St Clair EW, Tedder TF.

J Immunol. 2007 Jul 15;179(2):1369-80.

16.

Emerging biologic therapies in rheumatoid arthritis: cell targets and cytokines.

Singh R, Robinson DB, El-Gabalawy HS.

Curr Opin Rheumatol. 2005 May;17(3):274-9. Review.

PMID:
15838236
17.

Oral tolerance: mechanisms and possible role in inflammatory joint diseases.

Kagnoff MF.

Baillieres Clin Rheumatol. 1996 Feb;10(1):41-54. Review.

PMID:
8674148
18.

Rheumatoid factor revisited.

Dörner T, Egerer K, Feist E, Burmester GR.

Curr Opin Rheumatol. 2004 May;16(3):246-53. Review.

PMID:
15103252
19.

B cells: a fundamental role in the pathogenesis of rheumatoid arthritis?

Panayi GS.

Rheumatology (Oxford). 2005 May;44 Suppl 2:ii3-ii7. Review.

PMID:
15851524

Supplemental Content

Support Center